Overweight and obesity are associated with clustering of metabolic risk factors in early pregnancy and the risk of GDM

PLoS One. 2019 Dec 3;14(12):e0225978. doi: 10.1371/journal.pone.0225978. eCollection 2019.

Abstract

Aim: Overweight and obesity are important risk factors of gestational diabetes mellitus (GDM). Clustering of metabolic risk factors in early pregnancy may be a potential pathogenesis between the link of overweight/obesity and GDM. Since it remains unexplored, we investigated if overweight and obesity are associated with clustering of metabolic risk factors in early pregnancy and the risk of GDM in this cohort study.

Methods: Total 527 women who visited National Taiwan University Hospital for prenatal care in between November 2013 to April 2018 were enrolled. Risk factors of GDM in the first prenatal visit (FPV) were recorded. Overweight/obesity was defined if body mass index ≥24 kg/m2. GDM was diagnosed from the result of a 75g oral glucose tolerance test in 24-28 gestational weeks.

Results: Overweight/obesity was associated with clustering of metabolic risk factors of GDM, including high fasting plasma glucose, high HbA1c, insulin resistance, high plasma triglyceride and elevated blood pressure in FPV (p<0.05). There was a positive relationship between the number of metabolic risk factors and the incidence of GDM (p <0.05). The odds ratios of HbA1c and diastolic blood pressure were higher in overweight/obese women, compared with those in normal-weight women.

Conclusions: Overweight/obesity is associated with clustering of metabolic risk factors in early pregnancy, which is correlated with higher risk of GDM. Our findings suggest that metabolic risk factors during early pregnancy should be evaluated in overweight/obese women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers
  • Diabetes, Gestational / epidemiology*
  • Diabetes, Gestational / etiology*
  • Disease Susceptibility
  • Energy Metabolism*
  • Female
  • Gestational Age
  • Humans
  • Obesity / complications*
  • Obesity / epidemiology*
  • Obesity / metabolism
  • Overweight / complications*
  • Overweight / epidemiology*
  • Overweight / metabolism
  • Pregnancy
  • Risk Assessment
  • Risk Factors
  • Young Adult

Substances

  • Biomarkers

Grants and funding

This work is supported in part by grants (MOST 103-2314-B-002-157-MY2 and MOST 106-2314-B-002-197) from the Ministry of Science and Technology, Taiwan, and a grant (NTUH.107-S3744) from National Taiwan University Hospital, Taiwan to to H-YL and C-NL.